Artivion's ARTIZEN Trial Marks Milestone with First Patient Treated Using Arcevo LSA Artivion, Inc. has successfully treated the first patient in the ARTIZEN trial, designed to assess the Arcevo LSA Hybrid Stent Graft System for aortic arch pathologies.

Artivion's ARTIZEN Trial Marks Milestone with First Patient Treated Using Arcevo LSA #United_States #Atlanta #Artivion #Arcevo_LSA #ARTIZEN_Trial